Emcure Pharmaceuticals Ltd Share Price (EMCURE)
Check the latest share price of Emcure Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Emcure Pharmaceuticals Ltd Stock Performance
Get live Emcure Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹1,325Day's Price Range₹1,390.652 Week's Low
52 Week's High
₹88952-Week Price Range₹1,580
| Returns % | |
| 1 Month Return | + 28.97 % |
| 3 Month Return | + 47.09 % |
| 1 Year Return | + 0.17 % |
| 3 Year Return | + 0.17 % |
| 5 Year Return | + 0.17 % |
| Market Stats | |
| Previous Close | ₹1,375.90 |
| Open | ₹1,350.00 |
| Volume | 5.52L |
| Upper Circuit | ₹1,444.60 |
| Lower Circuit | ₹1,307.10 |
Emcure Pharmaceuticals Ltd Fundamentals & Key Indicators
Check Emcure Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹6.24 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Industry PE ratio
57.39
Beta (LTM)
0.32
P/B Ratio
-0.04
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
62.98
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
How to invest in Emcure Pharmaceuticals Ltd?
Investing in Emcure Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Emcure Pharmaceuticals Ltd or EMCURE on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Emcure Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Emcure Pharmaceuticals Ltd with just a few clicks!
Emcure Pharmaceuticals Ltd Stock's Interest Amongst Investors
Emcure Pharmaceuticals Ltd Valuation
Track how Emcure Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (37.54x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 37.54x
Emcure Pharmaceuticals Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Emcure Pharmaceuticals Ltd.
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
66.67% of analysts recommend a 'BUY' rating for Emcure Pharmaceuticals Ltd. Average target price of ₹1458.33
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd price forecast by 3 analysts
Upside of7.12%
High
₹1625
Target
₹1458.33
Low
₹1350
Emcure Pharmaceuticals Ltd target price ₹1458.33, a slight upside of 7.12% compared to current price of ₹1361.4. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Emcure Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Emcure Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Emcure Pharmaceuticals Ltd, including revenue, profit, loss and more.
Indices Featuring Emcure Pharmaceuticals Ltd Stock
Check stock indices that include Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 64.07% since last year same period to ₹188.96Cr in the Q4 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 22.92% jump in its net profits since last 3-months.
Read More about Earnings Results
Emcure Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Emcure Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 77.92% | 0.00 | |
| Foreign Institutions | 3.07% | 0.00 | |
| Mutual Funds | 2.73% | 0.00 | |
| Retail Investors | 15.57% | 0.00 | |
| Others | 0.71% | 0.00 |
Emcure Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 | |
| NA | 375.28 | 30.71% | 0.51 | NA | NA |
Emcure Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Reports Strong Financial Growth - 27 May, 2025
Emcure Pharmaceuticals reported consolidated net sales of Rs 2,116.25 crore for March 2025, a 19.47% increase year-on-year. Net profit surged 64.07% to Rs 188.96 crore, while EBITDA rose 25.92% to Rs 406.86 crore. EPS increased to Rs 9.97 from Rs 6.36.Emcure Pharmaceuticals Reports Strong Q4 Earnings Surge - 23 May, 2025
Emcure Pharmaceuticals reported a 63% increase in Q4 profit to Rs 197 crore, with revenue rising 19.5%. The stock surged nearly 20% over three days, supported by a positive price target revision from Kotak. The board proposed a final dividend of ₹3 per share, reflecting strong financial performance.Emcure Pharmaceuticals Reports Strong Q4 Results and Expansion Plans - 22 May, 2025
Emcure Pharmaceuticals reported a significant 63% increase in Q4 net profit, reaching ₹197 crore, alongside a 19.5% revenue rise. The company plans to expand its gynaecology and dermatology portfolio in FY26, indicating a positive outlook for growth.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, EMCURE stock has moved up by 29.0%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 3.05% to 3.07% in Mar 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 15.14% to 15.57% in Mar 2025 quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 77.94% to 77.92% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.10% to 2.73% in Mar 2025 quarter
About Emcure Pharmaceuticals Ltd
Revenue: ₹2,116.25Cr as on March 2025 (Q4 FY25)
Net Profit: ₹197.24Cr as on March 2025 (Q4 FY25)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own Emcure Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Emcure Pharmaceuticals Ltd.
FAQs
What is Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹1361.4, Open: ₹1350, Previous Close: ₹1375.9, High: ₹1390.6, Low: ₹1325, 52 Week High: ₹1580, 52 Week Low: ₹889.
What is today's traded volume of Emcure Pharmaceuticals Ltd?
Today's traded volume of Emcure Pharmaceuticals Ltd is 5.52L. Which means that 5.52L shares of Emcure Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Emcure Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Emcure Pharmaceuticals Ltd is ₹25,796.26 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd’s 52 week high is ₹1580 and 52 week low is ₹889. The current share price of Emcure Pharmaceuticals Ltd is ₹1361.4, which is -13.84% down from its 52 week high and 53.14% up from its 52 week low.